Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Marcus Jonathan William Dalton has worked on the following 25 EPO patent applications which have been published in the last five years:

EP11721756

NOVEL PROCESS

IPC classification:
C08B 37/00, C12P 19/04
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Multiple attorneys, GlaxoSmithKline
Status:
EXAMINATION IN PROGRESS
EP11724201

NOVEL PROCESS

IPC classification:
A61K 9/00, A61K 9/107, A61K 39/00
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Multiple attorneys, GlaxoSmithKline
Status:
EXAMINATION IN PROGRESS
EP11724202

NOVEL PROCESS

IPC classification:
A61K 9/00, A61K 9/107, A61K 39/00, A61K 47/06, A61K 47/22
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Multiple attorneys, GlaxoSmithKline
Status:
EXAMINATION IN PROGRESS
EP12723216

INACTIVATED DENGUE VIRUS VACCINE

IPC classification:
A61K 39/12, A61K 47/10
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Multiple attorneys, GlaxoSmithKline
Status:
GRANT OF PATENT INTENDED
EP12713175

FERMENTATION PROCESS

IPC classification:
A61K 39/02, C07K 14/195, C07K 14/34, C12P 21/00
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Multiple attorneys, GlaxoSmithKline
Status:
EXAMINATION REQUESTED
EP12771540

FUSION PROTEINS AND COMBINATION VACCINES COMPRISING HAEMOPHILUS INFLUENZAE PROTEIN E AND PILIN A

IPC classification:
A61K 39/145, A61K 39/385, A61P 31/16, A61P 37/04, C07K 14/285, C07K 19/00, C12N 15/00, C12P 21/02
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Multiple attorneys, GlaxoSmithKline
Status:
GRANT OF PATENT INTENDED
EP11707193

IMMUNOGENIC COMPOSITION

IPC classification:
A61K 39/095, A61K 39/116, C07K 14/22
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Multiple attorneys, GlaxoSmithKline
Status:
EXAMINATION REQUESTED
EP11707192

IMMUNOGENIC COMPOSITION

IPC classification:
A61K 39/095, A61K 39/116, C07K 14/22
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Multiple attorneys, GlaxoSmithKline
Agent:
Michael John Lubienski, GlaxoSmithKline Intellectual Property Management Limited
Status:
EXAMINATION REQUESTED
EP11757268

VACCINE AGAINST N. MENINGITIDIS

IPC classification:
A61K 39/095
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Multiple attorneys, GlaxoSmithKline
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12794675

VACCINE COMPRISING A TLR-5 AGONIST AS ADJUVANT FOR USE IN CUTANEOUS IMMUNISATION

IPC classification:
A61K 39/29, A61K 39/39, A61P 31/22
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Multiple attorneys, GlaxoSmithKline
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12791145

VACCINE

IPC classification:
A61K 39/29, A61K 39/39
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Multiple attorneys, GlaxoSmithKline
Status:
EXAMINATION IN PROGRESS
EP12772735

LIPOSOME PRODUCTION USING ISOPROPANOL

IPC classification:
A61K 9/127, A61K 47/36
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Multiple attorneys, GlaxoSmithKline
Status:
GRANT OF PATENT INTENDED
EP12707745

PROCESS FOR CONJUGATION OF BACTERIAL ANTIGEN TO A CARRIER PROTEIN

IPC classification:
A61K 39/02, A61K 47/48, A61P 31/04
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Multiple attorneys, GlaxoSmithKline
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13742207

PROCESS FOR THE PURIFICATION OF SAPONINS

IPC classification:
C07H 1/08, C07H 15/256
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Multiple attorneys, GlaxoSmithKline
Status:
EXAMINATION IN PROGRESS
EP13811876

CONJUGATES FOR PROTECTING AGAINST DIPHTHERIA AND/OR TETANUS

IPC classification:
A61K 39/00, C07H 1/00
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Marcus Jonathan William Dalton, GlaxoSmithKline
Status:
GRANT OF PATENT INTENDED
EP14704537

INTRADERMAL DELIVERY OF IMMUNOLOGICAL COMPOSITIONS COMPRISING TOLL-LIKE RECEPTOR AGONISTS

IPC classification:
A61K 39/39
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Marcus Jonathan William Dalton, GlaxoSmithKline
Status:
EXAMINATION IN PROGRESS
EP14705488

PHARMACEUTICAL COMPOSITIONS COMPRISING VESICLES

IPC classification:
A61K 9/50
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Marcus Jonathan William Dalton, GlaxoSmithKline
Status:
EXAMINATION REQUESTED
EP14700602

CYCLOALKYNE DERIVATIZED SACCHARIDES

IPC classification:
A61K 38/00, A61K 47/48, C08B 37/00
Applicant:
GlaxoSmithKline Biologicals SA
Applicant:
Novartis AG
Agent:
Marcus Jonathan William Dalton, GlaxoSmithKline
Status:
GRANT OF PATENT INTENDED
EP14709704

RNA PURIFICATION METHODS

IPC classification:
C12N 15/09
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Marcus Jonathan William Dalton, GlaxoSmithKline
Status:
EXAMINATION IN PROGRESS
EP15182862

NEISSERIAL ANTIGENIC PEPTIDES

IPC classification:
A61K 39/095, A61K 39/40, A61K 48/00, C07K 14/22, C07K 16/12, C12N 15/31, G01N 33/53, G01N 33/569
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Agent:
Marcus Jonathan William Dalton, GlaxoSmithKline
Status:
EXAMINATION IN PROGRESS
EP11708449

VACCINE COMPOSITION

IPC classification:
A61K 39/095, A61K 39/116, C07K 14/22
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Multiple attorneys, GlaxoSmithKline
Agent:
Michael John Lubienski, GlaxoSmithKline Intellectual Property Management Limited
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11716419

METHOD FOR INACTIVATING INFLUENZA VIRUS

IPC classification:
A61K 39/12, A61K 39/145, C12N 7/06
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Multiple attorneys, GlaxoSmithKline
Status:
PATENT GRANTED
EP11700859

MODIFIED TUBERCULOSIS ANTIGENS

IPC classification:
A61K 39/04, C07K 14/35
Applicant:
Glaxo Group Limited
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Marcus Jonathan William Dalton, GlaxoSmithKline
Status:
PATENT GRANTED
EP11776775

IMMUNOGENIC COMPOSITIONS AND METHODS FOR TREATING NEUROLOGIC DISORDERS

IPC classification:
A61K 31/00, A61K 31/7008, A61K 31/7056, A61K 39/00, A61K 39/39, A61K 39/395, A61P 25/28
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Multiple attorneys, GlaxoSmithKline
Status:
PATENT GRANTED
EP15713532

NOVEL METHODS FOR INDUCING AN IMMUNE RESPONSE

IPC classification:
A61K 39/002, A61K 39/015, A61K 39/29, A61K 39/39
Agent:
Multiple attorneys, GlaxoSmithKline
Status:
EXAMINATION REQUESTED

Please Sign in to use this feature